Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Superoxidized electrolyzed solution (SES) is more effective for burn healing than common antiseptics.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.

Understanding gender differences in COVID-19 is crucial for effective health strategies.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

Microthermal wounds heal with less scarring due to delayed collagen production and minimal inflammation.

CRISPR/Cas9 gene-editing may effectively treat hair loss but requires more research for safe use.

Cannabinoids may help treat various skin conditions.

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Composite biodegradable biomaterials can improve diabetic wound healing but need more development for clinical use.

Targeting Vδ1+T-cells may help treat alopecia areata.

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Excimer laser therapy can be an alternative for treating superficial morphea when topical steroids don't work.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

Phototherapy can help treat hair loss in alopecia areata.

Targeting TRP channels may help reduce excessive scarring.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.